AID203390 | Binding affinity towards human Somatostatin receptor type 1 (sst1) using Tyr11-[125I]-SRIF as radioligand was determined in CHO cells | 2003 | Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
| A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. |
AID1204627 | Apparent permeability from apical to basolateral side in human Caco2 cells by LC-MS analysis | 2015 | European journal of medicinal chemistry, Jun-05, Volume: 97 | Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability. |
AID234075 | Selectivity for in vitro inhibitory activity (Ki) against human recombinant hsst3 and hsst2 receptors | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID1204626 | Apparent permeability of the compound at 50 uM after 5 hrs by PAMPA method | 2015 | European journal of medicinal chemistry, Jun-05, Volume: 97 | Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability. |
AID203083 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst2) expressed in CHO cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203579 | In vitro inhibition of radioligand binding to human Somatostatin receptor type 5 expressed in CCL-39 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203077 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst1) expressed in hSF6 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203551 | Binding affinity towards human Somatostatin receptor type 3 (sst3) using Tyr11-[125I]-SRIF as radioligand was determined in CHO cells | 2003 | Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
| A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. |
AID203224 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst3) expressed in CHO cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID234076 | Selectivity for in vitro inhibitory activity (Ki) against human recombinant hsst5 and hsst2 receptors | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203409 | Binding affinity towards human Somatostatin receptor type 2 (sst2) using Tyr11-[125I]-SRIF as radioligand was determined in CHO cells | 2003 | Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
| A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. |
AID203583 | In vitro inhibition of radioligand binding to human Somatostatin receptor type 5 expressed in CHO-K1 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID234074 | Selectivity for in vitro inhibitory activity (Kd) against human recombinant hsst5 and hsst2 receptors | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203227 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst3) expressed in CHO-K1 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID234073 | Selectivity for in vitro inhibitory activity (Kd) against human recombinant hsst3 and hsst2 receptors | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203234 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst4) expressed in CHO cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203088 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst2) expressed in CHO-K1 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID195175 | In vitro GH release inhibiting potency on anterior pitutaries from adult male rats, relative to somatostatin | 1995 | Journal of medicinal chemistry, May-26, Volume: 38, Issue:11
| Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies. |
AID247988 | Antiproliferative activity against human epidermiod carcinoma A431 cells | 2005 | Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
| Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid. |
AID203080 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst1) expressed in CHO-K1 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203238 | In vitro inhibition of radioligand binding to human somatostatin receptor (hsst4) expressed in CHO-K1 cells. | 1998 | Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
| Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. |
AID203709 | Binding affinity towards human Somatostatin receptor type 5 (sst5) using Tyr11-[125I]-SRIF as radioligand was determined in COS cell | 2003 | Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
| A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. |
AID203570 | Binding affinity towards human Somatostatin receptor type 4 (sst4) using Tyr11-[125I]-SRIF as radioligand was determined in CHO cells | 2003 | Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
| A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |